Immunology and Breast Cancer

Every disease causes an immune response, which is the first line of defence against the spread of any malignancy. In the case of breast cancer, a connection exists between the immune system and the development of tumours. The environment around the tumour contains a variety of immune cells that may be able to stop the spread of breast cancer. These immune cells may be modulated by therapies used to treat breast cancer. Antigen-specific immunoglobulin is secreted by B lymphocytes, and it may have anticancer characteristics. Breast cancer patients have more B lymphocytes in their bone marrow than healthy individuals do, which can be an important factor in the therapy of breast cancer.

  • Immunogenicity of Breast Cancer
  • Anti-PD-1/PD-L1 Agents in Breast Cancer

Related Conference of Immunology and Breast Cancer

March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK
March 24-25, 2025

10th World Conference on Breast and Cervical Cancer

Paris, France
April 28-29, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
May 26-27, 2025

15th World Congress on Breast Cancer

Rome, Italy
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
October 13-14, 2025

8th International Conference on Anti-Cancer Drugs & Therapies

Aix-en-Provence, France
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain

Immunology and Breast Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in